Enhabit (NYSE:EHAB - Get Free Report) is expected to be releasing its Q1 2025 earnings data after the market closes on Wednesday, May 7th. Analysts expect Enhabit to post earnings of $0.07 per share and revenue of $266.11 million for the quarter.
Enhabit Price Performance
EHAB traded up $0.17 during trading hours on Friday, hitting $8.02. The company's stock had a trading volume of 414,965 shares, compared to its average volume of 481,085. The stock has a market cap of $404.85 million, a price-to-earnings ratio of -3.46 and a beta of 1.60. The business's 50-day moving average price is $8.28 and its 200-day moving average price is $8.02. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit has a 12 month low of $6.85 and a 12 month high of $10.70.
Analysts Set New Price Targets
Separately, Jefferies Financial Group reaffirmed a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.
Get Our Latest Stock Analysis on Enhabit
Enhabit Company Profile
(
Get Free Report)
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Read More
Before you consider Enhabit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.
While Enhabit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
